Imagion Biosystems Limited (ASX:IBX)

Australia · Delayed Price · Currency is AUD

0.0200

0.00 (0.00%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research & Development			4.97M	3.07M	2.86M	2.70M	2.49M
Research & Development Growth			61.87%	7.54%	5.88%	8.31%	570.28%
Total			4.97M	3.07M	2.86M	2.70M	2.49M
Total Growth			61.87%	7.54%	5.88%	8.31%	570.28%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Australia			3.60M	49.75K	10.48K	2.70M	2.49M
Australia Growth			7133.84%	374.98%	-99.61%	8.31%	570.28%
United States of America			1.37M	520.21K	232.93K	-	-
United States of America Growth			163.67%	123.33%	-	-	-
Total			4.97M	569.96K	243.41K	2.70M	2.49M
Total Growth			772.13%	134.16%	-90.97%	8.31%	570.28%

Source: S&P Global Market Intelligence.